Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.070
+0.140 (7.25%)
At close: Jan 17, 2025, 4:00 PM
2.090
+0.020 (0.97%)
Pre-market: Jan 21, 2025, 8:51 AM EST
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $451.64 million as of January 21, 2025. Its market cap has increased by 74.98% in one year.
Market Cap
451.64M
Enterprise Value
520.81M
1-Year Change
74.98%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $451.64M, a decrease of -7.47%. That is a compound annual growth rate of -0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 451.60M | 8.95% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |